The heterozygous inactivation of Brg1, however, produces mice that are viable but that invariably develop breast-like tumors within 1 year [38]; in murine lung cancer models, a lung-specific carcinogen combined with Brg1 inactivation significantly potentiates lung cancer development [48]. This evidence concerns the gene SMARCA4 and lung cancer.